Allergen Immunotherapy prior to conception and during pregnancy
Question:
11/17/2021
I have a long-standing patient who is on maintenance AIT with no serious reactions who is looking to get pregnant. Are there guidelines for AIT in patients who are attempting conception and during the subsequent pregnancy? The patient presented this question to me and I would like to get your expert's answer for her.
Answer:
According to the AIT Practice Parameter Third Update, starting AIT during pregnancy is not recommended and if a patient is on build-up (and not on a dose that is likely to be therapeutic) during pregnancy, then the Practice Parameters state that discontinuation of AIT should be considered. If a patient is on maintenance dose AIT, as in the case of your patient, then it is fine to continue at the same dose during the pregnancy. The key point is that the dose should not be increased during pregnancy, because of concern for a severe reaction that might cause problems for the fetus.
A more recent (2015) review found only 2 studies (1 using SCIT and 1 using SLIT) in which AIT was initiated during pregnancy. These studies were conducted in a small number of patients. No significant differences in maternal or fetal complications compared to control patients were observed.
Both the AAAAI and ACAAI Joint Task Force and the EAACI discourage the initiation of AIT during pregnancy.
References
Cox L, Nelson H, Lockey R. Allergen Immunotherapy: A Practice Parameter Third Update. J Allergy Clin Immunol 2011;127:S1.
Oykhman P, Kim HL, Ellis AK. Allergen Immunotherapy in Pregnancy. Allergy Asthma Clin Immunol 2015;11:31.
I hope this helps you with your patient.
Jacqueline A. Pongracic, MD, FAAAAI